// App-Quantinova.ai

1161 : International Good Clinical Practices Guidelines (GCPG) for Antithrombotics in CANCER Patients

Researchers

Presenter

  • Debourdeau Philippe

Principal Investigators

  • Ajay Kakkar

  • Alok A. Khorana

  • Ramon Lecumberri

  • Mario Mandala

  • Daniela Cilloni

  • Michel Marthy

  • Manuel Monreal

  • Shaker S Mousa

  • Simon Noble

  • Ingrid Pabinger

  • Caroline Baglin

  • Paolo Prandoni

  • Martin Prins

  • Mohammed H. Qari

  • Michael B. Streiff

  • Konstantin Syrigos

  • Henri Bounameaux

  • Harry Roger Buller

  • Rupert Bauersachs

  • Benjamin Brenner

  • Dialina Brilhante

  • Anna Falanga

  • Grigoris T Gerotziafas

  • Nissim Haim

Medical Centers

  • University Hospital of Parma, Parma, Italy

  • Department of Hematology, King Abdulaziz University Hospital, Jeddah, Saudi Arabia

  • Pulmonary Medicine, Academic Medical Centre, Amsterdam, Netherlands

  • Immunohematology and Transfusion Medicine-Thrombosis & Servico de Imuno hemoterapia, Departamento de Hematologia, Instituto Portugues de Oncologia Lisboa Francisco Gentil, Lisboa, Portugal

  • Department of Oncology & Department of Haematology, University Clinic of Navarra, Pamplona, Spain

  • Department of Hematology, University Hospital Groningen, Groningen, Netherlands

  • Clinical Epidemiology and Technology Assessment, University Medical Center, Maastricht, Netherlands

  • Centre des Innovations Therapeutiques en Oncologie et Hematologie CITOH, Hopital Saint-Louis, Paris, France

  • Service -Hematologie Biologique, Hopital Tenon Assistance Publique Hopitaux de Paris, France, Paris, France

  • Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

  • Thrombosis and Hemostasis Unit, Rambam Health Care Campus and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel

  • Oncology Unit, Athens School of medecine, Athens, Greece

  • Internal Medicine and Oncology Department, Desgenettes Military Hospital, Lyon, France

  • Servicio de Medicina Interna, Hospital Universitario Germans Trias i Pujol, Barcelona, Spain

  • Sorbonne Paris Cite, INSERM U , Paris Diderot University, Paris, France

  • Department of Palliative Medicine, Cardiff University, Royal Gwent Hospital, Newport, United Kingdom

  • Institute of Oncology, Rambam Health Care Campus, Haifa, Israel

  • Ospedali Riuniti di Bergamo, Bergamo, Italy

  • Thrombosis Research Institute and University College London, London, United Kingdom

  • Dept. of Medicine I, Div. of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria

  • Ospedali Riuniti, Bergamo, Italy

  • University Hospital Geneva, Geneva, Switzerland

  • Klinikum Darmstadt GmbH

Locations

  • Saudi Arabia

  • Italy

  • Greece

  • Austria

  • Netherlands

  • Spain

  • United Kingdom

  • Switzerland

  • Portugal

  • Israel

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Pulmonary embolism

  • Thrombocytopenia

  • Brain cancer

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

  • Creatinine

  • Ecdysoneless

  • Folate Hydrolase 1

Drug/Treatment

  • Heparin

  • Fondaparinux sodium

  • Asparaginase

  • Aspirin

  • Albyl-E

  • Heparin

Outcome

  • N/A

Study Design

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved